DrugPatentWatch Database Preview
Drugs in Development Information for KHK7580
Email this page to a colleague
What is the drug development status for KHK7580?
KHK7580 is an investigational drug.
There have been 9 clinical trials for KHK7580.
The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2019.
The most common disease conditions in clinical trials are Hyperparathyroidism, Hyperparathyroidism, Secondary, and Neoplasm Metastasis. The leading clinical trial sponsors are Kyowa Hakko Kirin Co., Ltd, Kyowa Hakko Kirin Company, Limited, and Kyowa Hakko Kirin China Pharmaceutical Co., LTD.
There are four US patents protecting this investigational drug and thirty-seven international patents.
Summary for KHK7580
| US Patents | 4 |
| International Patents | 37 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 3 (2019-04-01) |
| Vendors | 12 |
Recent Clinical Trials for KHK7580
| Title | Sponsor | Phase |
|---|---|---|
| Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers | Kyowa Hakko Kirin China Pharmaceutical Co., LTD. | Phase 1 |
| Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers | Kyowa Kirin Co., Ltd. | Phase 1 |
| Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia | Kyowa Hakko Kirin China Pharmaceutical Co., LTD. | Phase 3 |
Clinical Trial Summary for KHK7580
Top disease conditions for KHK7580
Top clinical trial sponsors for KHK7580
US Patents for KHK7580
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| KHK7580 | ⤷ Try it Free | Pharmaceutical composition containing an arylalkylamine compound | KYOWA HAKKO KIRIN CO., LTD. (Chiyoda-ku, JP) | ⤷ Try it Free |
| KHK7580 | ⤷ Try it Free | Arylalkylamine compound and process for preparing the same | Mitsubishi Tanabe Pharma Corporation (Osaka-Shi, JP) | ⤷ Try it Free |
| KHK7580 | ⤷ Try it Free | Arylalkylamine compound and process for preparing the same | Mitsubishi Tanabe Pharma Corporation (Osaka, JP) | ⤷ Try it Free |
| KHK7580 | ⤷ Try it Free | Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid | MITSUBISHI TANABE PHARMA CORPORATION (Osaka, JP) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for KHK7580
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| KHK7580 | China | CN108135883 | 2035-10-07 | ⤷ Try it Free |
| KHK7580 | European Patent Office | EP3360551 | 2035-10-07 | ⤷ Try it Free |
| KHK7580 | Japan | JP2017071599 | 2035-10-07 | ⤷ Try it Free |
| KHK7580 | Japan | JP2017071605 | 2035-10-07 | ⤷ Try it Free |
| KHK7580 | Japan | JP6168673 | 2035-10-07 | ⤷ Try it Free |
| KHK7580 | South Korea | KR102000897 | 2035-10-07 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
